March 28, 2018 / 3:50 PM / in 24 days

BRIEF-U.S. FDA Says U.S.Court Files Permanent Injunction Against MyNicNaxs LLC Of Florida

March 28 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA SAYS A U.S. DISTRICT COURT ENTERED A CONSENT DECREE OF PERMANENT INJUNCTION BETWEEN THE U.S. AND MYNICNAXS LLC OF DELTONA, FLORIDA

* U.S. FDA SAYS THE U.S. DISTRICT COURT ALSO ENTERED THE CONSENT DECREE BETWEEN THE U.S. & MYNICNAXS’ OWNER CHEVONNE TORRES AND OFFICER MICHAEL BANNER

* U.S. FDA - AS PER COMPLAINT FILED WITH CONSENT DECREE, FDA TESTS SHOWED SOME OF MYNICNAXS’ PRODUCTS CONTAINED UNDISCLOSED PHARMACEUTICAL INGREDIENTS

* U.S. FDA - SOME OF THE UNDISCLOSED PHARMACEUTICAL INGREDIENTS THAT SHOWED IN MYNICNAXS’ PRODUCTS WERE SILDENAFIL, SIBUTRAMINE, AND PHENOLPHTHALEIN

* U.S. FDA - PERMANENT INJUNCTION REQUIRES MYNICNAXS, DEFENDANTS TO CEASE DIRECTLY/INDIRECTLY DISTRIBUTING ANY UNAPPROVED NEW DRUGS OR MISBRANDED DRUGS Source text: (bit.ly/2Gf9Uf1)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below